How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Post Translational Modification Analysis Services Market
- By Service Type: Phosphorylation Analysis, Glycosylation Analysis, Ubiquitination Analysis, Acetylation Analysis, Methylation Analysis, Sumoylation Analysis
- By Technology Platform: Mass Spectrometry, Chromatography, Western Blotting, ELISA, Protein Microarrays
- By End-user: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs), Diagnostic Laboratories, Agricultural Biotechnology Firms
- By Application: Biomarker Discovery, Drug Development & Validation, Proteomics Research, Disease Mechanism Studies, Quality Control & Assurance
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Phosphorylation Analysis leads By Service Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 284 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.171 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.179 →
Full report · locked preview
Everything inside the Post Translational Modification Analysis Services Market report
A complete, evidence-based study - 11 chapters and 119 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Service Type 6
Technology Platform 5
End-user 5
Application 5
Companies profiled
Thermo Fisher Scientific
Agilent Technologies
Bruker Corporation
SCIEX (a Danaher company)
Waters Corporation
Bio-Rad Laboratories
PerkinElmer
Shimadzu Corporation
Cytiva (formerly GE Healthcare Life Sciences)
Promega Corporation
New England Biolabs
Cell Signaling Technology
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Agilent Technologies
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Bruker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →SCIEX (a Danaher company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Waters Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Bio-Rad Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →PerkinElmer
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Shimadzu Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Cytiva (formerly GE Healthcare Life Sciences)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Promega Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →New England Biolabs
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Cell Signaling Technology
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Abcam
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →MilliporeSigma (Merck KGaA)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Proteome Sciences
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,673M by 2033 · 7.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Phosphorylation Analysis43.6
- Glycosylation Analysis17.8
- Ubiquitination Analysis10.2
- Acetylation Analysis7.3
- Methylation Analysis6.5
- Sumoylation Analysis14.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,197M → $2,367M · 8.9%
Europe$834.3M → $1,457M · 7.2%
Asia Pacific$761.8M → $1,542M · 9.2%
Latin America$471.6M → $783.2M · 6.5%
Middle East and Africa$362.7M → $695.6M · 8.5%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.872026
7.882027
7.902028
7.912029
7.922030
7.932031
7.942032
7.962033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific24.9
- Agilent Technologies10.2
- Bruker Corporation10.9
- SCIEX (a Danaher company)10.6
- Waters Corporation10.7
- Bio-Rad Laboratories4.7
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Service Type14.7%
Technology Platform31.1%
End-user35.2%
Application19.0%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.6
- Europe21.3
- Asia Pacific22.5
- Latin America11.4
- Middle East and Africa10.2
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 76 | 96 | 86 | 82 | 94 | 89 | 87 |
| Agilent Technologies | 83 | 78 | 79 | 69 | 78 | 74 | 77 |
| Bruker Corporation | 68 | 63 | 83 | 69 | 75 | 65 | 71 |
| SCIEX (a Danaher company) | 64 | 80 | 76 | 62 | 82 | 65 | 72 |
| Waters Corporation | 57 | 65 | 60 | 76 | 67 | 62 | 65 |
| Bio-Rad Laboratories | 69 | 64 | 48 | 68 | 58 | 53 | 60 |
| PerkinElmer | 62 | 56 | 60 | 55 | 43 | 64 | 57 |
| Shimadzu Corporation | 45 | 40 | 58 | 48 | 42 | 58 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- Agilent Technologies
- Bruker Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ◐ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Agilent Technologies | ◐ | ◐ | ◐ | − | ✓ | ◐ |
| Bruker Corporation | ◐ | − | ✓ | ◐ | − | ◐ |
| SCIEX (a Danaher company) | ◐ | ◐ | ◐ | ◐ | ◐ | ✓ |
| Waters Corporation | − | ✓ | ◐ | ◐ | ◐ | − |
| Bio-Rad Laboratories | ◐ | − | − | ◐ | − | ◐ |
| PerkinElmer | ◐ | ◐ | − | − | − | ◐ |
| Shimadzu Corporation | − | ◐ | ◐ | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific87
2Agilent Technologies77
3SCIEX (a Danaher company)72
4Bruker Corporation71
5Waters Corporation65
6Bio-Rad Laboratories60
7PerkinElmer57
8Shimadzu Corporation49
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Thermo Fisher Scientific
Challenger3
Strong scale, closing on the leaders.
Agilent TechnologiesBruker CorporationSCIEX (a Danaher company)
Contender3
Focused players with pockets of strength.
Waters CorporationBio-Rad LaboratoriesPerkinElmer
Niche1
Specialists in a single segment or region.
Shimadzu Corporation
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Service Type in North America, then scale across Post Translational Modification Analysis Services Market — a $504M beachhead inside a $8.27B market.
Beachhead (SOM)$504Mobtainable near-term
Serviceable (SAM)$2.94Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Phosphorylation Analysis
Best fit — highest urgency & budget in Service Type.
Economic buyer79 fit
Glycosylation Analysis
Strong fit — clear ROI and a fast path to value.
End user69 fit
Ubiquitination Analysis
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Service Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Technology Platform & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End-user
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales41%
Partner / channel30%
Digital / self-serve21%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Service Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Post Translational Modification Analysis Services Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified22%
Evaluation14%
Closed-won7%
$20.7KCAC
$110KLTV
5.3:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Post Translational Modification Analysis Services Market is a durable-growth opportunity — $4.15B by 2033, compounding at 6.9%.
TAM · 2025$2.42Btoday
TAM · 2033$4.15Bforecast
CAGR6.9%2027–2033
Cumulative$29.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.15BTotal addressable market
SAM$1.63BServiceable available market
SOM$300MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.9% CAGR
Demand compounds through 2033, outpacing GDP across Service Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Service Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.15BLarge & growingTAM by 2033 at 6.9% CAGR
$1.63BServiceable nowreachable with today’s model
$300MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.24BBear4.5% CAGR
$4.15BBase6.9% CAGR
$5.31BBull9.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Technology Platform optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Post Translational Modification Analysis Services Market — a $9.09B market by 2033. Plan: grow share from 8.1% to 14.4%.
Market size · 2033$9.09Btotal addressable
Market CAGR10.0%2027–2033
Target share14.4%from 8.1% today
Revenue ambition$1.31Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.1% | 14.4% | Ahead |
| Revenue | $766M | $1.31B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | At risk |
| Gross margin | 37.8% | 42.1% | On track |
| Customer retention | 87.1% | 96.1% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Service Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Technology Platform capability
A defensible second engine — invest in Technology Platform to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Service Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Technology Platform
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $174M capacity & capability investment
- Greenlight bolt-on M&A in Technology Platform
- Authorise North America expansion plan
- Fund R&D program for Service Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAt risk
- Input-cost & supply riskBehind
- Regulatory / policy changeBehind
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Post Translational Modification Analysis Services Market conversation — a $8.32B market you can size, segment and defend in minutes.
Market size · 2033$8.32Btotal opportunity
Growth7.7%CAGR to 2033
Addressable buyers1,513+accounts in scope
Typical ROI6.1×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Service Type
Goal Grow share in Service Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.1×return on cost, year one
< 2 mopayback period
$57K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Thermo Fisher ScientificAgilent TechnologiesBruker CorporationSCIEX (a Danaher company)Waters CorporationBio-Rad LaboratoriesPerkinElmerShimadzu Corporation+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Post Translational Modification Analysis Services Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Post Translational Modification Analysis Services Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Post-Surgical Scar Treatment Market
Market size, share, segmentation and regional forecast.
$541M market · 2025 base year
View reportPost Surgical Dressing Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportPost Surgical Compression Tights Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportPost Surgical Compression Stockings Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportPost Surgical Compression Garments Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportPost-Surgical Compression Bras Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportPost Surgical Compression Bra Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportPost-Surgical Compression Bandage Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportPost Surgery Recovery Bra Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportPost Surgery Compression Garment Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportPostpartum Rehabilitation Therapy Instruments Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportPostpartum Rehabilitation Service Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.